Wells Fargo & Company Lexicon Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 76,489 shares of LXRX stock, worth $62,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,489

Previous 45,601 67.74%

Holding current value

$62,720

Previous $76,000 57.89%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.51 - $2.39 $46,640 - $73,822	30,888 Added 67.74%	76,489 $120,000
Q2 2024 Aug 13, 2024	BUY	$1.54 - $2.28 $22,462 - $33,256	14,586 Added 47.03%	45,601 $76,000
Q1 2024 May 10, 2024	BUY	$1.3 - $3.58 $5,564 - $15,322	4,280 Added 16.01%	31,015 $74,000
Q4 2023 Feb 09, 2024	BUY	$1.0 - $1.53 $5,571 - $8,523	5,571 Added 26.32%	26,735 $40,000
Q3 2023 Nov 13, 2023	SELL	$1.06 - $2.33 $16,600 - $36,490	-15,661 Reduced 42.53%	21,164 $23,000
Q2 2023 Aug 15, 2023	BUY	$2.15 - $3.49 $46,143 - $74,902	21,462 Added 139.7%	36,825 $84,000
Q1 2023 May 12, 2023	BUY	$1.99 - $2.68 $30,572 - $41,172	15,363 New	15,363 $37,000
Q3 2022 Nov 14, 2022	SELL	$1.94 - $3.43 $1,098 - $1,941	-566 Reduced 42.65%	761 $2,000
Q2 2022 Aug 12, 2022	SELL	$1.31 - $2.69 $233,998 - $480,501	-178,625 Reduced 99.26%	1,327 $2,000
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $609,919 - $1.22 Million	-312,779 Reduced 63.48%	179,952 $376,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $229,483 - $371,029	-60,232 Reduced 10.89%	492,731 $1.94 Million
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $877,295 - $1.39 Million	259,555 Added 88.46%	552,963 $2.66 Million
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $1.01 Million - $1.44 Million	244,808 Added 503.72%	293,408 $1.35 Million
Q1 2021 May 13, 2021	SELL	$3.45 - $9.09 $30,660 - $80,782	-8,887 Reduced 15.46%	48,600 $285,000
Q4 2020 Feb 09, 2021	SELL	$1.05 - $3.67 $97,236 - $339,864	-92,606 Reduced 61.7%	57,487 $197,000
Q3 2020 Nov 05, 2020	BUY	$1.44 - $2.1 $59,653 - $86,994	41,426 Added 38.12%	150,093 $216,000
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.3 $360 - $473	206 Added 0.19%	108,667 $217,000
Q1 2020 May 14, 2020	BUY	$1.8 - $4.28 $195,229 - $464,213	108,461 New	108,461 $212,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $155M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Lexicon Pharmaceuticals, Inc. Transaction History